Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To CytokineticsPRNewsWire • 11/23/20
Amgen, Inc. (AMGN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript)Seeking Alpha • 11/18/20
Amgen, AstraZeneca Stocks Pop On 'Best-Case' Outcome For Asthma DrugInvestors Business Daily • 11/10/20
These Red-Hot Biotechs Are Leading The Pack And Could Be ActionableInvestors Business Daily • 11/10/20
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe AsthmaPRNewsWire • 11/10/20
Amgen Inc. (AMGN) Management Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)Seeking Alpha • 11/10/20
Amgen Showcases New Data Across Cardiovascular Portfolio At AHA Scientific Sessions 2020: A Virtual ExperiencePRNewsWire • 11/09/20
Need to Know: These 7 unloved stocks are for the long haul, says contrarian managerMarket Watch • 11/05/20
Amgen Inc. (AMGN) CEO Robert Bradway on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/29/20